Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7223761 Salts and polymorphs of a potent antidiabetic compound

Patent 7223761 was granted and assigned to Amgen on May, 2007 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 11 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12083107 Pharmaceutical compositions comprising glitazones and Nrf2 activators
0
Edits on 16 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 16 Sep, 2023
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Bing Yang0
Henry T. Kruk0
Lawrence R. McGee0
Edits on 1 Sep, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 1 Sep, 2023
Edits made to:
Article (+536 characters)
Article

Patent abstract

Salts and polymorphs of a compound useful in the treatment of inflammatory and metabolic conditions and diseases are provided herein. In particular, the invention provides salts and polymorphs of a compound which modulates the expression and/or function of a peroxisome proliferator-activated receptor. The salts and polymorphs are useful for the treatment or prevention of conditions and disorders associated with energy homeostasis such as type II diabetes, lipid metabolism, adipocyte differentiation and inflammation.

Edits on 15 Jul, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 15 Jul, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07223761 Salts and polymorphs of a potent antidiabetic compound US Patent 7223761 Salts and polymorphs of a potent antidiabetic compound

Infobox
Patent Number
072237610
Patent Number
72237610
Edits on 21 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=072237610
Edits on 24 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Amgen
Amgen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
072237610
Date of Patent
May 29, 2007
0
Patent Application Number
109562510
Date Filed
October 1, 2004
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=072237610
Patent Primary Examiner
‌
D. Margaret Seaman
0
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=07223761
Edits on 21 Nov, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 21 Nov, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 07223761 Salts and polymorphs of a potent antidiabetic compound

Infobox
Is a
Patent
Patent
Current assignee
Amgen
Amgen
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
07223761
Date of patent
May 29, 2007
Patent application number
10956251
Date Filed
October 1, 2004
Patent primary examiner
‌
D. Margaret Seaman

Find more entities like US Patent 7223761 Salts and polymorphs of a potent antidiabetic compound

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo